| phase III trial |
The third and usually final stage in testing a new drug in humans. Used to collect information about the safety of a drug and how well it works. Once this phase is complete, the drug manufacturers may request permission from the Food and Drug Administration to market the drug.
Ãâó: www.aegis.com/pubs/cria/2003/CR030902.html
|
|---|---|
| phase III trial |
Once a treatment has been shown to be effective against a cancer, it is studied in a phase III trial to compare the new treatment with the standard treatment regimen. Safety, effectiveness, dosage, and side effects are all evaluated. More people are needed in phase III trials than in phase 11 trials to determine whether the new treatment is better than the standard treatment.
Ãâó: nydailynews.healthology.com/nydailynews/15836.htm
|
| phase III trial |
Compares two or more kinds of treatment in two or more similar groups of patients, with one group of patients receiving the standard, or control, therapy.
Ãâó: dfw-neuronetwork.com/Glossary.htm
|
| phase III trial |
A study that compares a new treatment to the current standard of care. The study is designed to look for various results, such as 1) the new drug or method of giving the drug may be more effective, or 2) it may be as effective but safer, or 3) it may be somewhat less effective but less toxic and less expensive, or 4) it can be given over a shorter period of time and/or on an easier schedule. ...
Ãâó: saci.uthscsa.edu/PatientServices/glossary.html
|
| phase III trial |
Compares a new treatment with demonstrated efficacy in Phase II trials against the best established therapies
Ãâó: www.umich.edu/~newsinfo/Releases/2001/Aug01/glossa...
|